NCT06618703 2026-04-06
BIChE-1
University Hospital, Angers
Phase NA Recruiting
Clinical Trials
11 trialsNCT05692635 2026-03-20
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT07467109 2026-03-19
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
M.D. Anderson Cancer Center
Not yet recruiting
NCT05890781 2026-02-09
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT03526822 2026-01-28
MM-Predict
Assistance Publique Hopitaux De Marseille
Phase NA Recruiting
NCT03465618 2026-01-07
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT07226466 2025-11-10
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
Not yet recruiting
NCT04785521 2025-06-11
Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
IRCCS San Raffaele
Active not recruiting
NCT05775458 2025-06-11
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
IRCCS San Raffaele
Recruiting
NCT01674582 2020-09-03
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Phase NA Completed
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed